Hair transplant or restoration:
relocating follicles versus saving them

When does hair loss need a transplant?

Hair loss needs a transplant when follicles in a zone have gone and the donor area can spare enough to cover it. The clinical sign is a hairline or crown that has been smooth and shine-bare for some time, with no fine miniaturised hairs left to work with. No medicine, laser or injection brings back a follicle that has been lost, so in that situation relocation is the realistic tool and the patient is referred to an appropriate surgical specialist.

Most people who ask about a hair transplant are not yet in that position. Androgenetic alopecia works by miniaturisation: under the influence of dihydrotestosterone (DHT), susceptible follicles produce progressively finer, shorter hairs over successive cycles before they stop. A scalp that looks thin in photographs often still carries a large population of these miniaturising follicles, and they are exactly what medical and non-surgical treatment is aimed at.

The distinction is made by examination rather than in the mirror. Trichoscopy shows whether thinning zones still hold miniaturised hairs, staging on the Norwood scale in men or the Ludwig scale in women describes the pattern, and blood tests look for iron, thyroid and other contributors where shedding or female thinning is involved. The answer can differ across one scalp: a bare temple and a thinning crown are not the same decision.

What can non-surgical treatment do for living follicles?

Non-surgical treatment aims to slow miniaturisation and support the follicles that remain; it does not create new ones. That is a smaller promise than a transplant appears to make, but it acts on the process a transplant leaves untouched, which is why the medical side comes first in most plans.

Prescription medicines form the foundation for pattern hair loss. Oral DHT-pathway therapy such as finasteride reduces the conversion of testosterone to DHT, and minoxidil, topical or low-dose oral, prolongs the growth phase of the hair cycle. They are described here for education only: each needs a doctor's assessment, a discussion of side effects such as changes in libido with finasteride or unwanted hair growth and fluid retention with oral minoxidil, and a decision about suitability, including for women who are or may become pregnant.

Around that foundation, Dr Sin Yong's hair restoration programme uses H2LT, a calibrated laser stimulation of the scalp followed by low-level laser over the treated areas, and Regenera Activa, in which small punch samples of the patient's own DHT-protected scalp are processed into a micrograft suspension and injected into thinning areas. Neither moves follicles. Both are directed at the environment of follicles still present, and response varies between individuals.

“Relocating hair does not stop the hair loss that made the transplant necessary. Restoration comes before relocation, or you are transplanting into a receding field.”

Dr Sin YongOn hair restoration sequencing

FUE or FUT: how do the two transplant methods differ?

FUE and FUT both move the same thing, DHT-resistant follicles from the donor area; they differ in how the donor hair is taken. The donor region at the back and sides of the scalp is genetically resistant to the hormone that drives pattern loss, and relocated follicles generally keep that resistance in their new position. That is the whole basis of the procedure.

Follicular unit excision, usually called FUE, removes individual follicular units one at a time with a small punch. It leaves tiny scattered dot scars across the donor area, which is usually clipped short for the harvest. Follicular unit transplantation, or FUT, removes a strip of donor scalp that is then divided into grafts under magnification; the wound is closed and leaves a fine linear scar that is normally covered by the hair above it.

Neither method is better in the abstract. Which suits a given scalp depends on donor density and scalp laxity, how many grafts are needed now and may be needed later, whether a very short haircut matters, and the experience of the team performing it. Both are surgical procedures with local anaesthesia, wound care and their own risks, and the decision belongs to the surgical specialist after their own examination. Dr Sin Yong does not perform either method.

Why does medical therapy matter after a transplant?

Medical therapy matters after a transplant because the transplant does not treat androgenetic alopecia. The relocated follicles resist DHT, but the native hair around and behind them remains as susceptible as before, and it keeps miniaturising unless the underlying process is managed.

Left unmanaged, that progression changes how a transplant looks over time. Grafts placed along a hairline can end up as an isolated band in front of a crown that continues to thin, and the gap between transplanted and native hair becomes the new visible problem. Because donor follicles are finite, every graft spent chasing progression is one that cannot be used later.

This is why evidence-based guidance on androgenetic alopecia places hair transplantation alongside medical therapy rather than instead of it, and why continuing medical treatment is usually discussed as part of a transplant plan. The prescribing decision remains individual, and it is described here for education only: a doctor weighs the type of loss, medical history and side effects before anything is started or continued.

The medical side matters before surgery too. Stabilising loss first shows how much of the scalp is genuinely lost and how much was miniaturising and recoverable, which can change the size of the area a surgical team is asked to treat. For some scalps assessed and stabilised early, the conclusion is that surgery can be deferred; for others, it clarifies the zone where relocation makes sense.

Who is not a good candidate for a hair transplant?

A transplant is a poor fit when there is no stable, well-defined zone of loss or no adequate donor supply. The commonest example is a young man with rapidly progressing loss: placing a hairline now commits limited donor hair to a pattern that may look unnatural once the loss behind it advances. Hair that is still in active retreat is usually stabilised and re-examined before anyone designs a hairline.

Diffuse thinning is another. Many women with female pattern hair loss thin across the whole crown while the frontal hairline is preserved, and the donor area may itself be thinning, which leaves little to relocate and little stable ground to relocate it to. Diffuse shedding from telogen effluvium is a different condition altogether, usually driven by a trigger such as illness, childbirth or nutritional deficiency, and it is investigated rather than operated on.

Alopecia areata is autoimmune: follicles are attacked rather than lost, and patches can regrow, so it is managed medically. Scarring alopecias, in which inflammation destroys follicles, need dermatological assessment and a period of documented stability before any surgical question arises. In each of these, the first step is a diagnosis, not a procedure.

How is the decision made at assessment?

The decision follows the scalp zone by zone rather than a single verdict. At assessment Dr Sin Yong examines the hairline, mid-scalp and crown with trichoscopy, stages the pattern, reviews the donor area, and asks about family history, previous treatment and how quickly change has happened. Photographs taken in standardised conditions give a baseline against which later change is judged, whichever route is chosen.

From that, most scalps fall into one of three groups. Some have thinning with living follicles throughout, and the plan is medical and non-surgical. Some have a bare zone alongside thinning elsewhere, and the plan pairs a referral for a surgical opinion on the bare zone with medical management of the rest. A smaller group has stable, well-defined loss with an adequate donor area, where relocation is the main tool and the medical side protects the native hair around it.

Saying plainly which group you are in is the point of the consultation. A clinic that offers every scalp the same procedure, or that discusses graft numbers before anyone has looked through a trichoscope, has skipped the step that decides whether the procedure makes sense at all.